Hou N - Search Results

1

Angiogenesis inhibitors rechallenge in patients with advanced non-small-cell lung cancer: a pooled analysis of randomized controlled trials.

Zhao L, Li W, Zhang H, Hou N, Guo L, Gao Q. Zhao L, et al. Among authors: hou n. Onco Targets Ther. 2015 Oct 3;8:2775-81. doi: 10.2147/OTT.S88102. eCollection 2015. Onco Targets Ther. 2015. PMID: 26491352 Free PMC article.

2

T-cell immunoglobulin and mucin domain-containing protein-3 and galectin-9 protein expression: Potential prognostic significance in esophageal squamous cell carcinoma for Chinese patients.

Hou N, Ma J, Li W, Zhao L, Gao Q, Mai L. Hou N, et al. Oncol Lett. 2017 Dec;14(6):8007-8013. doi: 10.3892/ol.2017.7188. Epub 2017 Oct 16. Oncol Lett. 2017. PMID: 29344243 Free PMC article.

3

High expression of NDRG3 associates with unfavorable overall survival in non-small cell lung cancer.

Luo X, Hou N, Chen X, Xu Z, Xu J, Wang L, Yang S, Liu S, Xu L, Chen Y, Xiong L, Wang J, Fan W, Xu J. Luo X, et al. Among authors: hou n. Cancer Biomark. 2018 Feb 6;21(2):461-469. doi: 10.3233/CBM-170711. Cancer Biomark. 2018. PMID: 29171988

4

ROR1 associates unfavorable prognosis and promotes lymphoma growth in DLBCL by affecting PI3K/Akt/mTOR signaling pathway.

Mao Y, Xu L, Wang J, Zhang L, Hou N, Xu J, Wang L, Yang S, Chen Y, Xiong L, Zhu J, Fan W, Xu J. Mao Y, et al. Among authors: hou n. Biofactors. 2019 May;45(3):416-426. doi: 10.1002/biof.1498. Epub 2019 Feb 24. Biofactors. 2019. PMID: 30801854

5

CXCR7 expression in nasopharyngeal carcinoma tissues correlates with disease severity.

Zhu L, Luo K, Gu XH, Hou N, Huang CP, Lou Q, Dai XZ, Zhang K. Zhu L, et al. Among authors: hou n. Int J Clin Exp Med. 2015 Nov 15;8(11):21257-61. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26885064 Free PMC article.

6

Dysregulated circular RNAs are closely linked to multiple myeloma prognosis, with circ_0026652 predicting bortezomib‑based treatment response and survival via the microRNA‑608‑mediated Wnt/β‑catenin pathway.

Li L, Liu J, Du J, Jiang H, He H, Lu J, Qiang W, Hou N, Guo P, Zhuang Y, Fu W. Li L, et al. Among authors: hou n. Oncol Rep. 2022 Nov;48(5):195. doi: 10.3892/or.2022.8410. Epub 2022 Sep 21. Oncol Rep. 2022. PMID: 36129153 Free PMC article.

7

Tissue-engineered larynx using perfusion-decellularized technique and mesenchymal stem cells in a rabbit model.

Hou N, Cui P, Luo J, Ma R, Zhu L. Hou N, et al. Acta Otolaryngol. 2011 Jun;131(6):645-52. doi: 10.3109/00016489.2010.547517. Epub 2011 Feb 18. Acta Otolaryngol. 2011. PMID: 21332294

8

Tissue-engineered esophagus: recellular esophageal extracellular matrix based on perfusion-decellularized technique and mesenchymal stem cells.

Hou N, Xu X, Lv D, Lu Y, Li J, Cui P, Ma R, Luo X, Tang Y, Zheng Y. Hou N, et al. Biomed Mater. 2021 Aug 27;16(5). doi: 10.1088/1748-605X/ac1d3d. Biomed Mater. 2021. PMID: 34384057

9

[The efficacy and safety of daratumumab in relapsed and refractory multiple myeloma].

Liu J, He HY, Li L, Lu J, Qiang WT, Guo P, Hou N, Jiang H, Du J, Fu WJ. Liu J, et al. Among authors: hou n. Zhonghua Xue Ye Xue Za Zhi. 2021 Jan 14;42(1):27-32. doi: 10.3760/cma.j.issn.0253-2727.2021.01.006. Zhonghua Xue Ye Xue Za Zhi. 2021. PMID: 33677865 Free PMC article. Chinese.

10

[A preliminary study on the preparation of perfusion-decellularized laryngeal scaffold and the feasibility of laryngeal muscle reconstruction].

Hou N, Cui PC, Chen WX, Luo JS, Ma RN. Hou N, et al. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2009 Jul;44(7):586-90. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2009. PMID: 19957658 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

743 results

Search Page

Filters